teva pharmaceuticals introduces the first generic glp-1 for weight loss Wegovy Pill Wins FDA Approval as Oral Treatment Obesity and Oral GLP-1 Medication Helps Patients
Description
"Myostatin/activin receptor ligands in muscle and the development status of attenuating drugs." Endocrine Reviews 43.2 (2022): 329-365
Clinical trial data and post-marketing surveillance have not confirmed an increased incidence of medullary thyroid carcinoma in GLP-1RA-treated patients, though long-term monitoring continues [30,31]
The goal is to use enough medication to support meaningful clinical improvement while preserving nutrition, muscle, function, and long-term adherence
The camaraderie and culture of it, it wasnt really high-level, more like people were there to have fun
